期刊文献+

少数民族活体肾移植受者人群的糖尿病患病情况及相关危险因素分析 被引量:6

An analysis of diabetes prevalence and associated risk factors of the minority Renal Transplant recipients
下载PDF
导出
摘要 目的了解并探讨少数民族活体肾移植术后存活1a以上受者的糖尿病患病情况及相关危险因素。方法对2004年7月-2013年6月接受活体肾移植手术的少数民族患者116例进行回顾性分析,根据世界卫生组织制订的糖尿病诊断标准诊断是否发生肾脏移植后糖尿病(PTDM),将患者分成PTDM组(16例)和N-PTDM组(100例),对可调节和不可调节危险因素进行单因素分析。结果 (1)116例少数民族活体肾移植受者中有16例在肾移植术后1a患有新发糖尿病,PTDM的患病率为13.8%。(2)单因素分析提示两组术前年龄、体质指数(BMI)、术前丙型肝炎病毒(HCV)感染、术前甘油三酯(TG)异常的差异具有统计学意义(P<0.05)。两组术前总胆固醇(TC)异常、术前空腹血糖受损、糖尿病家族史、吸烟史、乙型肝炎病毒(HBV)感染、巨细胞病毒(CMV)感染差异无统计学意义(P>0.05)。术后使用环孢素A或FK506、发生急性排斥反应、术前年龄≥45岁、BMI≥25kg/m2与PTDM明显相关(P<0.01)。结论少数民族活体肾移植患者的PTDM发生率较高,应早期预防、早期诊断、早期治疗,减少糖尿病在肾移植患者的发生与发展。 Objective To investigate and explore the prevalence of diabetes and related risk factors in the minority Renal Transplant recipients who survived more than a year.Methods 1 1 6 minority patients who were given living donor renal transplantation from July,2004 to June 2013 were retrospectively analyzed and were divided into PTDM group (16 cases)and N-PTDM group (100 cases)according to Post-trans-plantation diabetes mellitus (PTDM),the diagnostic criteria for diabetes made by World Health Organiza-tion.Single factor analysis was performed with t-test andχ2 test.Results (1 )1 6 new-onset diabetes oc-curred among the 1 1 6 cases of minority Renal Transplantation,making the prevalence of PTDM of 1 3 .8%. (2)Single factor analysis revealed that preoperative age,body mass index (BMI),preoperative hepatitis C virus (HCV)infection,preoperative triglyceride (TG)anomalies were statistically significant (P 〈0.05).There was no significant difference (P &gt;0.05)in abnormal preoperative total cholesterol (TC), preoperative impaired fasting glucose,diabetes family history,smoking history,hepatitis B virus (HBV)infection,cytomegalovirus (CMV)infection,etc.Postoperative use of cyclosporine A or FK506,acute re-jection,preoperative age ≥45 years old,BMI≥25 kg/m2 were significantly associated with PTDM (P 〈0.01).Conclusion PTDM incidence of minority living donor kidney transplant patients shares the same with that of literature at home and abroad with an exclusion of cadaver donors reported in literatures as an independent risk factor.Early prevention,diagnosis and treatment help reduce the occurrence and develop-ment of the diabetes in patients with renal transplantation.
出处 《新疆医科大学学报》 CAS 2014年第10期1261-1263,1268,共4页 Journal of Xinjiang Medical University
基金 国家重点基础研究发展计划(973计划)(2012CB722403) 新疆重大疾病医学重点实验室开放课题(SKLIB-XJMDR-2012-Y4) 新疆医科大学研究生科研创新基金(XJGRI2013083)
关键词 肾移植 移植后糖尿病 患病率 危险因素 Renal Transplantation diabetes after transplantation prevalence risk factors
  • 相关文献

参考文献10

  • 1王育璠,彭永德.肾移植后糖尿病的研究进展[J].国际内分泌代谢杂志,2008,28(5):351-353. 被引量:1
  • 2陈敏灵,于明香.肾移植术后空腹血糖、血脂变化规律与影响因素分析[D].上海:复旦大学,2010.
  • 3Montori VM, Velosa J A, Basu A,et al. Posttransplantation di- ahetes: Asystematic review o( the literature[J].Diahetes Care, 2002,25: 583-592.
  • 4Pham PT,Pham PM,Pham SV, et al.New onset diabetes after transplantation(NODAT) : an overview [J]. Diabetes Metab Syndr Obes, 2011,175-186,.
  • 5Xu Y,Liang JX,Liu B,et al.Prevalence and long-term glucose me- tabolism evolution of post. transplant diabetes mellitus in Chinese renal recipients[J].Diabetes Res Clin Pract, 2011,92 : 11-18.
  • 6陈敏灵,张尧,于明香,许明,高键,高鑫.肾移植术后糖尿病的发病及其危险因素分析[J].中华内分泌代谢杂志,2013,29(9):750-755. 被引量:14
  • 7Mathew JT, Rao M, Job V, et al.Post transplant hyperglycae- mia:a study of risk factorsp[J].Nephrol Dial Transplant, 2003,18 : 164-171.
  • 8Gnatta D,Keitel E, H eineck I,et al.Use of tacrolimus and the development of post-transplant diabetes mellitus: a Brazilian single-center, observational study [ J ]. Transplant Proc, 2010, 42 :475-478.
  • 9Hamer RA,Chow CL,Ong AC,et al.Polyeystic kidney disease is a risk factor for new onset diabetes after transplantation[J]. Transplantation, 2007,83 (1) : 36-40.
  • 10陈雄.肾移植术后糖尿病流行病学调查及其与维生素D受体基因多态性关系研究[D].广州:中山大学,2007.

二级参考文献37

  • 1蔡锦全,谭建明,董维平,王煜菲,王鉴波.免疫抑制剂对成人胰岛细胞的毒性作用的体外观察[J].中华医学杂志,2005,85(10):654-656. 被引量:8
  • 2Kasiske BL, Snyder JJ, Gilbertson D, et al. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant ,2003,3: 178-185.
  • 3Numakura K, Satoh S,Tsuchiya N, et al. Incidence and risk factors of clinical characteristics, tacrolimus pharmacokinetics, and related genomic polymorphisms for posttransplant diabetes mellitus in the early stage of renal transplant recipients. Transplant Proc, 2005, 37 : 1865-1867.
  • 4Sezer S, Bilgic A, Uyar M, et al. Risk factors for development of posttransplant diabetes mellitus in renal transplant recipients. Transplant Proc ,2006,38:529-532.
  • 5Wyzgal J, Paczek L, Sanko-Resmer J, et al. Insulin resistance in kidney allograft recipients treated with calcineurin inhibitors. Ann Transplant, 2007,12 : 26 -29.
  • 6Mazali FC, Lalli CA, Alves-Filho G, et al. Posttransplant diabetes mellitus : incidence and risk factors. Transplant Proc, 2008,40 : 764-766.
  • 7Hoitsma AJ, Hilbrands LB. Relative risk of new-onset diabetes during the first year after renal transplantation in patients receiving tacrolimus or cyclosporine immunosuppression. Clin Transplant ,2006, 20:659-664.
  • 8Marcen R, Morales JM, del Castillo D, et al. Posttransplant diabetes mellitus in renal allograft recipients :A prospective multicenter study at 2 years. Transplant Proc,2006 ,38 :3530-3532.
  • 9Teutonico A, Schena PF, Di Paolo S, et al. Glucose metabolism in renal transplant recipients : effect of calcineurin inhibitor withdrawal and conversion to sirolimus. J Am Soc Nephrol,2005,16 : 3128- 3135.
  • 10Wilkinson A, Davidson J, Dotta F, et al. Guidelines for the treatment and management of new-onset diabetes after transplantation. Clin Transplant ,2005,19:291-298.

共引文献13

同被引文献75

引证文献6

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部